Table 4.
Variable | Athletes With Frequent PVBs (>500/24 Hours), PVBs Induced by Exercise or Complex VA (N=17) | Control Athletes With <10 Isolated PVBs (N=17) | P Value |
---|---|---|---|
LV EDV, mL/mq | 85 (76–94) | 87 (78–97) | 0.73 |
LV EF, % | 61 (56–68) | 58 (57–64) | 0.43 |
Maximum LV wall thickness, mm | 9 (8–10) | 9 (8–9) | 0.84 |
Regional LV WMA | 0 | 0 | ··· |
RV EDV, mL/mq | 86 (74–93) | 82 (76–95) | 0.64 |
RV EF, % | 55 (51–63) | 59 (57–67) | 0.38 |
Regional RV WMA | 0 | 0 | ··· |
LV myocardial edema | 0 | 0 | ··· |
LV LGEa | 3 (18) | 0 | 0.23 |
RV LGE | 0 | 0 | ··· |
Pericardial LGE | 0 | 0 | ··· |
Data are given as median (25th–75th percentile) or number (percentage). CMR indicates cardiac magnetic resonance; EDV, end‐diastolic volume; EF, ejection fraction; LGE, late gadolinium enhancement; LV, left ventricular; PVB, premature ventricular beat; RV, right ventricular; VA, ventricular arrhythmia; WMA, wall motion abnormality.
Excluding isolated junctional LGE.